EMA: ‘No Going Back’ On Decentralized Trials
A senior official from the European Medicines Agency says the COVID-19 pandemic has changed the future clinical trials landscape for good.
You may also be interested in...
Plans Press On To Harmonize Decentralized Clinical Trial Requirements In EU
Participants from all areas of the research community will be able to share their perspectives on decentralized clinical trials with the EU regulators, who plan to publish recommendations on the topic later this year.
Minute Insight: Amazon Partners With Thread To Help Decentralize Clinical Trials
Thread, a technology and consulting service provider, signed a deal with Amazon Web Services to enable faster, more efficient subject monitoring and data collection in clinical trials.
Denmark Outlines Vision For Decentralized Trials Beyond COVID-19
The Danish medicines regulator has set out its expectations on key elements of decentralized clinical trials as part of Denmark’s ongoing effort to develop a robust regulatory framework in this area.